VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $164,000 | +5366.7% | 825 | +3337.5% | 0.00% | – |
| Q4 2014 | $3,000 | -99.8% | 24 | -99.8% | 0.00% | -100.0% |
| Q3 2014 | $1,379,000 | +4.0% | 10,513 | 0.0% | 0.01% | +16.7% |
| Q2 2014 | $1,326,000 | -4.3% | 10,513 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $1,386,000 | +12.3% | 10,513 | 0.0% | 0.01% | +16.7% |
| Q4 2013 | $1,234,000 | +12.8% | 10,513 | +0.2% | 0.01% | +20.0% |
| Q3 2013 | $1,094,000 | +35.6% | 10,489 | +11.9% | 0.01% | +25.0% |
| Q2 2013 | $807,000 | – | 9,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |